DK0703978T3 - Medium til langtidsproliferation og -udvikling af celler - Google Patents

Medium til langtidsproliferation og -udvikling af celler

Info

Publication number: DK0703978T3
Authority: DK; Denmark
Prior art keywords: cells; medium; development; growth factor; serum
Prior art date: 1993-06-18

Application number

DK94920264T

Other languages

English (en)

Inventor

Ian L O Ponting

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-18

Filing date

1994-06-17

Publication date

2000-01-17

1994-06-17 Application filed by Amgen Inc filed Critical Amgen Inc

2000-01-17 Application granted granted Critical

2000-01-17 Publication of DK0703978T3 publication Critical patent/DK0703978T3/da

Links

230000011712 cell development Effects 0.000 title abstract 2
230000004663 cell proliferation Effects 0.000 title abstract 2
230000007774 longterm Effects 0.000 title abstract 2
210000004027 cell Anatomy 0.000 abstract 3
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
230000018109 developmental process Effects 0.000 abstract 2
210000003958 hematopoietic stem cell Anatomy 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
239000002609 medium Substances 0.000 abstract 2
230000035755 proliferation Effects 0.000 abstract 2
102000008186 Collagen Human genes 0.000 abstract 1
108010035532 Collagen Proteins 0.000 abstract 1
102000009024 Epidermal Growth Factor Human genes 0.000 abstract 1
101800003838 Epidermal growth factor Proteins 0.000 abstract 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
102000018233 Fibroblast Growth Factor Human genes 0.000 abstract 1
108050007372 Fibroblast Growth Factor Proteins 0.000 abstract 1
102000016359 Fibronectins Human genes 0.000 abstract 1
108010067306 Fibronectins Proteins 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 abstract 1
102000007547 Laminin Human genes 0.000 abstract 1
108010085895 Laminin Proteins 0.000 abstract 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 abstract 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 abstract 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 1
102000007562 Serum Albumin Human genes 0.000 abstract 1
108010071390 Serum Albumin Proteins 0.000 abstract 1
102000004338 Transferrin Human genes 0.000 abstract 1
108090000901 Transferrin Proteins 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
210000004271 bone marrow stromal cell Anatomy 0.000 abstract 1
239000003638 chemical reducing agent Substances 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
229920001436 collagen Polymers 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229940116977 epidermal growth factor Drugs 0.000 abstract 1
210000002744 extracellular matrix Anatomy 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
229940126864 fibroblast growth factor Drugs 0.000 abstract 1
239000003862 glucocorticoid Substances 0.000 abstract 1
239000003102 growth factor Substances 0.000 abstract 1
239000001963 growth medium Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
239000002777 nucleoside Substances 0.000 abstract 1
125000003835 nucleoside group Chemical group 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1
210000002536 stromal cell Anatomy 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1
239000012581 transferrin Substances 0.000 abstract 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Developmental Biology & Embryology (AREA)
Hematology (AREA)
Microbiology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

DK94920264T 1993-06-18 1994-06-17 Medium til langtidsproliferation og -udvikling af celler DK0703978T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/079,719 US5405772A (en)	1993-06-18	1993-06-18	Medium for long-term proliferation and development of cells
PCT/US1994/006893 WO1995000632A1 (en)	1993-06-18	1994-06-17	Medium for long-term proliferation and development of cells

Publications (1)

Publication Number	Publication Date
DK0703978T3 true DK0703978T3 (da)	2000-01-17

Family

ID=22152362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94920264T DK0703978T3 (da)	1993-06-18	1994-06-17	Medium til langtidsproliferation og -udvikling af celler

Country Status (11)

Country	Link
US (1)	US5405772A (da)
EP (1)	EP0703978B1 (da)
JP (1)	JP2866742B2 (da)
AT (1)	ATE183544T1 (da)
AU (1)	AU678836B2 (da)
CA (1)	CA2165335A1 (da)
DE (1)	DE69420138D1 (da)
DK (1)	DK0703978T3 (da)
ES (1)	ES2135589T3 (da)
GR (1)	GR3031218T3 (da)
WO (1)	WO1995000632A1 (da)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5612211A (en) *	1990-06-08	1997-03-18	New York University	Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US6352707B1 (en)	1992-02-24	2002-03-05	Anton-Lewis Usala	Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US6231881B1 (en)	1992-02-24	2001-05-15	Anton-Lewis Usala	Medium and matrix for long-term proliferation of cells
US6037174A (en) *	1993-08-23	2000-03-14	Nexell Therapeutics, Inc.	Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
JPH07227278A (ja) *	1994-02-18	1995-08-29	Kyorin Pharmaceut Co Ltd	成熟中枢神経細胞用の無血清培地
US7083979B1 (en) *	1994-03-25	2006-08-01	Indiana University Foundation	Methods for enhanced retroviral-mediated gene transfer
DE4422667A1 (de) *	1994-06-30	1996-01-04	Boehringer Ingelheim Int	Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US5985554A (en) *	1994-11-02	1999-11-16	Takeda Chemical Industries, Ltd.	Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
US5719058A (en) *	1995-04-10	1998-02-17	Merck & Co., Inc.	Method for producing a highly enriched population of osteoclast cells
AU6125396A (en) *	1995-06-07	1996-12-30	Novartis Ag	Serum-free media for primitive hematopoietic cells and metho ds of use thereof
KR100793625B1 (ko) *	1995-09-29	2008-01-11	인디아나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션	바이러스-매개된 ｄｎａ 전달을 향상시키는 방법에 의해생산된 생존성 세포 집단 및 이를 포함하는 세포 조성물
BR9610802A (pt)	1995-10-04	1999-07-13	Immunex Corp	Método para melhoria da resposta imunológica método de preparo de células t de antígeno específico método para induzir tolerância de tecido de enxerto auxiliar de vacina meio de expansão e preparação de células dentríticas população de células dentríticas e respectivo método de preparo método para direcionar células-tronco hematopoiéticas ou células progenitoras a uma linhagem de células dentríticas
EP0891419A4 (en) *	1996-03-12	2000-03-01	Life Technologies Inc	NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
US6043092A (en) *	1996-03-18	2000-03-28	University Of Pittsburgh	Cell culture media for mammalian cells
EP0920490A2 (en) *	1996-07-25	1999-06-09	Genzyme Corporation	Chondrocyte media formulations and culture procedures
WO1998004680A1 (en) *	1996-07-26	1998-02-05	University Of Manitoba	Serum-free medium for growth of anchorage-dependant mammalian cells
EP2221361A3 (en) *	1996-08-30	2011-02-09	Life Technologies Corporation	Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
TW517089B (en) *	1996-09-03	2003-01-11	Res Dev Foundation	Assessment of intracellular cysteine and glutathione concentrations
US5945337A (en) *	1996-10-18	1999-08-31	Quality Biological, Inc.	Method for culturing CD34+ cells in a serum-free medium
JP2001508302A (ja) *	1997-01-10	2001-06-26	ライフテクノロジーズ，インコーポレイテッド	胚性幹細胞血清置換
US5948426A (en) *	1997-05-03	1999-09-07	Jefferies; Steven R.	Method and article to induce hematopoietic expansion
AU7984498A (en) *	1997-06-25	1999-01-04	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Serum-free cell growth medium
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
WO1999020740A2 (en)	1997-10-23	1999-04-29	Geron Corporation	Methods and materials for the growth of primate-derived primordial stem cells
WO1999031222A1 (en) *	1997-12-18	1999-06-24	Willem Frederik Van Eelen	Industrial scale production of meat from in vitro cell cultures
JP2002517982A (ja) *	1998-04-09	2002-06-25	ブレサゲンリミテッド	細胞の分化／増殖および維持因子ならびにそれらの使用
EP1096941B1 (en) *	1998-05-07	2005-08-10	University Of South Florida	Bone marrow cells as a source of neurons for brain and spinal cord repair
US7410798B2 (en)	2001-01-10	2008-08-12	Geron Corporation	Culture system for rapid expansion of human embryonic stem cells
US20020168766A1 (en) *	2000-01-11	2002-11-14	Gold Joseph D.	Genetically altered human pluripotent stem cells
US6667176B1 (en) *	2000-01-11	2003-12-23	Geron Corporation	cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
IL142914A0 (en)	1998-11-09	2002-04-21	Consorzio Per La Gestione Del	Serum free medium for chondrocyte-like cells
US7670628B2 (en) *	1999-07-07	2010-03-02	Angioblast Systems, Inc.	Mesenchymal precursor cell
US8062675B2 (en)	1999-07-07	2011-11-22	Angioblast Systems, Inc.	Mesenchymal precursor cell
US20050158289A1 (en) *	1999-07-07	2005-07-21	Simmons Paul J.	Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
AU2003901668A0 (en)	2003-03-28	2003-05-01	Medvet Science Pty. Ltd.	Non-haemopoietic precursor cells
AUPQ147799A0 (en) *	1999-07-07	1999-07-29	Medvet Science Pty. Ltd.	Mesenchymal precursor cell
US20030113301A1 (en) *	1999-07-23	2003-06-19	Albert Edge	Muscle cells and their use in cardiac repair
AU770889B2 (en)	1999-07-23	2004-03-04	Genvec, Inc.	Muscle cells and their use in cardiac repair
US20020187133A1 (en)	1999-10-01	2002-12-12	Hiroshi Kubota	Methods of isolating bipotent hepatic progenitor cells
US6811776B2 (en) *	2000-12-27	2004-11-02	The Regents Of The University Of Michigan	Process for ex vivo formation of mammalian bone and uses thereof
US7455983B2 (en) *	2000-01-11	2008-11-25	Geron Corporation	Medium for growing human embryonic stem cells
AU3685401A (en)	2000-02-11	2001-08-20	Philadelphia Health	Differentiation of bone marrow cells into neuronal cells and uses therefor
US7005252B1 (en) *	2000-03-09	2006-02-28	Wisconsin Alumni Research Foundation	Serum free cultivation of primate embryonic stem cells
US7439064B2 (en)	2000-03-09	2008-10-21	Wicell Research Institute, Inc.	Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US8119138B2 (en) *	2000-05-10	2012-02-21	Signe Biopharma Inc.	Anti-estrogen and immune modulator combinations for treating breast cancer
US20030072812A1 (en) *	2001-05-10	2003-04-17	Sirbasku David A	Breast cancer eradication program
US7947463B2 (en)	2000-05-10	2011-05-24	Signe Biopharma, Inc.	Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
US7863011B2 (en) *	2000-05-10	2011-01-04	Signe Biopharma, Inc.	Screening method for predicting susceptibility to breast cancer
HU230198B1 (hu)	2000-11-23	2015-10-28	Bavarian Nordic A/S	Módosított Vacciniavírus Ankara-variáns
US7445924B2 (en) *	2000-11-23	2008-11-04	Bavarian Nordic A/S	Modified Vaccinia Ankara virus variant and cultivation method
US7628980B2 (en) *	2000-11-23	2009-12-08	Bavarian Nordic A/S	Modified vaccinia virus ankara for the vaccination of neonates
EP1379626A2 (en) *	2001-04-19	2004-01-14	DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung	A method for differentiating stem cells into insulin-producing cells
JP4226909B2 (ja) *	2001-05-11	2009-02-18	財団法人化学及血清療法研究所	細胞障害抑制活性を有するペプチドおよび当該細胞障害抑制活性を有するペプチドのスクリーニング方法
WO2003064598A2 (en) *	2002-01-25	2003-08-07	Genzyme Corporation	Serum-free media for chondrocytes and methods of use thereof
WO2003084431A2 (en) *	2002-03-29	2003-10-16	Singapore Eye Research Institute	Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
EP1420822B2 (en) *	2002-04-19	2017-07-05	Bavarian Nordic A/S	Modified vaccinia virus ankara for the vaccination of neonates
US20040191225A1 (en) *	2002-08-06	2004-09-30	Dinsmore Jonathan H.	Injection system
AU2003264144C1 (en) *	2002-09-05	2009-12-17	Bavarian Nordic A/S	Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
EP1475434A1 (en) *	2003-05-09	2004-11-10	Oncoscience AG	Method for storing tumor cells
US7608455B2 (en) *	2003-08-20	2009-10-27	Becton, Dickinson And Company	Modified reconstituted basement membrane composition for assay system
EP1666589B1 (en) *	2003-08-22	2010-02-17	Takara Bio Inc.	Process for producing cytotoxic lymphocytes
JP5060134B2 (ja)	2003-12-12	2012-10-31	ガバメントオブザユナイテッドステイツオブアメリカ・アズリプレゼンテッドバイザセクレタリー・デパートメントオブヘルスアンドヒューマンサービシーズ	ヒト細胞傷害性Ｔリンパ球のエピトープ及びそのＭＵＣ−１の非ＶＮＴＲ（ｎｏｎ−ｖａｒｉａｂｌｅｎｕｍｂｅｒｏｆｔａｎｄｅｍｒｅｐｅａｔｓｅｑｕｅｎｃｅ）由来のアゴニストエピトープ
JP4651282B2 (ja) *	2004-01-21	2011-03-16	田辺三菱製薬株式会社	造血幹細胞及び造血前駆細胞の増幅方法
US20070009497A1 (en) *	2004-03-10	2007-01-11	Steinman Ralph M	Dendritic cell expanded T suppressor cells and methods of use thereof
US8252591B2 (en) *	2004-05-07	2012-08-28	Whitehead Institute For Biomedical Research	Hormone responsive tissue culture system and uses thereof
US7481080B2 (en) *	2004-07-01	2009-01-27	General Electric Company	Clothes washer braking method and apparatus
AU2005271723B2 (en)	2004-07-13	2010-12-16	Asterias Biotherapeutics, Inc.	Medium for growing human embryonic stem cells
CN101103101B (zh) *	2004-09-24	2012-10-10	成血管细胞系统公司	增强间充质前体细胞（mpc）的增生和/或存活的方法
JP5090928B2 (ja) *	2004-12-28	2012-12-05	ザロックフェラーユニバーシティ	Ｎｋｔ細胞に対する抗原としての糖脂質及びその類似体
US7923013B2 (en)	2004-12-28	2011-04-12	The Rockefeller University	Glycolipids and analogues thereof as antigens for NKT cells
US20070014795A1 (en) *	2004-12-30	2007-01-18	Dhodapkar Madhav V	Compositions and methods for enhanced dendritic cell maturation and function
US7837990B2 (en) *	2005-03-28	2010-11-23	The Rockefeller University	In vivo expanded NKT cells and methods of use thereof
CA2603857A1 (en) *	2005-03-31	2006-11-16	Mytogen, Inc.	Treatment for heart disease
US8889122B2 (en) *	2005-05-09	2014-11-18	Mytogen, Inc.	Cellular cardiomyoplasty as supportive therapy in patients with heart disease
US9074181B2 (en)	2005-06-22	2015-07-07	Asterias Biotherapeutics, Inc.	Suspension culture of human embryonic stem cells
US20070231901A1 (en) *	2005-12-02	2007-10-04	Shuichi Takayama	Microfluidic cell culture media
WO2007109583A2 (en)	2006-03-17	2007-09-27	The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
US20070280922A1 (en)	2006-06-06	2007-12-06	Zoltan Kiss Consulting	Combinations of human proteins to enhance viability of stem cells and progenitor cells
US20080003676A1 (en) *	2006-06-26	2008-01-03	Millipore Corporation	Growth of embryonic stem cells
EP1900810A1 (fr) *	2006-09-15	2008-03-19	Celogos	Methode d'extraction et de selection de cellules
EP2607477B1 (en)	2007-05-03	2020-09-23	The Brigham and Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US20110244502A1 (en)	2007-08-10	2011-10-06	Whitehead Institute For Biomedical Research	Hormone responsive tissue culture system and uses thereof
JP2009090160A (ja) *	2007-10-03	2009-04-30	Fujifilm Corp	乳化物または分散物の製造方法、並びにこれを含む食品、皮膚外用剤及び医薬品
EP2083071A1 (en) *	2008-01-25	2009-07-29	Cell Med Research GMBH	Medium for propagating and expanding stem cells
WO2009092789A1 (en) *	2008-01-25	2009-07-30	Cell Med Research Gmbh	Medium for propagating and expanding stem cells
WO2010035261A2 (en)	2008-09-29	2010-04-01	Ben Gurion University Of The Negev Research And Development Authority	Amyloid beta-peptides and methods of use thereof
PL2539441T3 (pl) *	2010-02-22	2017-06-30	Université Pierre Et Marie Curie (Paris 6)	Podłoże do hodowli komórkowej do wzrostu i różnicowania komórek linii hematopoetycznych
EP2556147B1 (en)	2010-04-08	2018-10-03	The University Court Of The University of Edinburgh	Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
JP6148429B2 (ja)	2011-01-31	2017-06-14	協和発酵バイオ株式会社	ヒト多能性幹細胞の培養方法
US10238723B2 (en)	2013-03-14	2019-03-26	Icahn School Of Medicine At Mount Sinai	Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
US9943545B2 (en) *	2013-03-15	2018-04-17	Fate Therapeutics, Inc.	Stem cell culture media and methods of enhancing cell survival
CA2943787A1 (en) *	2014-03-25	2015-10-01	Cook Biotech Incorporated	Extracellular matrix grafts loaded with exogenous factors
KR101668743B1 (ko) *	2014-08-08	2016-10-25	(주)세포바이오	식물 유래 재조합 인간 혈청 알부민 및 식물성 펩타이드를 유효성분으로 함유하는 세포 보존용 조성물
CN104830772A (zh) *	2015-05-28	2015-08-12	深圳富利鑫健康产业发展有限公司	一种造血干细胞培养基及其应用和干细胞培养方法
CN116113693A (zh)	2020-08-10	2023-05-12	谱系细胞疗法股份有限公司	用于胚胎干细胞扩增的组合物和方法
CN114381428A (zh) *	2022-01-21	2022-04-22	广东善玺迦纳栗生物科技股份有限公司	作用于注射皮下或损伤组织部位的细胞培养基

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4443546A (en) *	1980-07-07	1984-04-17	The Beth Israel Hospital Association	Process and composition for propagating mammalian cells
JPS57194787A (en) *	1981-05-28	1982-11-30	Ajinomoto Co Inc	Culture medium for animal cell
US4560655A (en) *	1982-12-16	1985-12-24	Immunex Corporation	Serum-free cell culture medium and process for making same
NZ206699A (en) *	1982-12-30	1989-08-29	Bio Response Inc	Process for the production of serum independent cell lines
FR2543158B1 (fr) *	1983-03-24	1985-11-15	Inst Nat Sante Rech Med	Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
US4940666A (en) *	1983-07-15	1990-07-10	University Patents, Inc.	Process and defined medium for growth of human epidermal keratinocyte cells
US5132223A (en) *	1983-11-10	1992-07-21	Thomas Jefferson University	Process and medium for cloning and long-term serial cultivation of adult human endothelial cells
JPS60196186A (ja) *	1984-03-17	1985-10-04	Agency Of Ind Science & Technol	低分子ゼラチンを含む付着依存性細胞用無血清培地組成物を用いる培養方法
US5030105A (en) *	1985-06-06	1991-07-09	Centro De Investigacion Y Estudios Avanzados Del Instituto Politecnico Nacional	Process for the long-term surviving culture of hepatocytes
US4816401A (en) *	1985-09-09	1989-03-28	University Of Rochester	Serum free cell culture medium
US5160490A (en)	1986-04-18	1992-11-03	Marrow-Tech Incorporated	Three-dimensional cell and tissue culture apparatus
NO162160C (no) *	1987-01-09	1989-11-15	Medi Cult As	Serumfritt vekstmedium, samt anvendelse derav.
DE3871206D1 (de) *	1987-03-24	1992-06-25	Grace W R & Co	Basisnaehrmedium fuer eine zellkultur.
US5143842A (en) *	1988-11-01	1992-09-01	The University Of Colorado Foundation, Inc.	Media for normal human muscle satellite cells
US5135866A (en) *	1989-03-03	1992-08-04	W. R. Grace & Co.-Conn.	Very low protein nutrient medium for cell culture
US5328844A (en) *	1990-05-09	1994-07-12	University Of Colorado Foundation, Inc.	Culture media for mammalian cells
ATE164076T1 (de) *	1990-06-08	1998-04-15	Univ New York	Stimulierung der stroma- und vorläuferzellen im knochenmark
US5122469A (en) *	1990-10-03	1992-06-16	Genentech, Inc.	Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
JPH0789908B2 (ja) *	1991-02-28	1995-10-04	倉敷紡績株式会社	動物細胞培養用無血清培地
WO1992018615A1 (en) *	1991-04-09	1992-10-29	Indiana University Foundation	System and process for supporting hematopoietic cells
AU2882992A (en) *	1991-11-06	1993-06-07	Arthur A. Axelrad	Cell culture medium

1993
- 1993-06-18 US US08/079,719 patent/US5405772A/en not_active Expired - Lifetime
1994
- 1994-06-17 DK DK94920264T patent/DK0703978T3/da active
- 1994-06-17 AU AU71124/94A patent/AU678836B2/en not_active Ceased
- 1994-06-17 WO PCT/US1994/006893 patent/WO1995000632A1/en not_active Ceased
- 1994-06-17 AT AT94920264T patent/ATE183544T1/de not_active IP Right Cessation
- 1994-06-17 CA CA002165335A patent/CA2165335A1/en not_active Abandoned
- 1994-06-17 DE DE69420138T patent/DE69420138D1/de not_active Expired - Lifetime
- 1994-06-17 EP EP94920264A patent/EP0703978B1/en not_active Expired - Lifetime
- 1994-06-17 ES ES94920264T patent/ES2135589T3/es not_active Expired - Lifetime
- 1994-06-17 JP JP7502993A patent/JP2866742B2/ja not_active Expired - Lifetime
1999
- 1999-09-16 GR GR990402309T patent/GR3031218T3/el unknown

Also Published As

Publication number	Publication date
JP2866742B2 (ja)	1999-03-08
DE69420138D1 (de)	1999-09-23
EP0703978B1 (en)	1999-08-18
ATE183544T1 (de)	1999-09-15
US5405772A (en)	1995-04-11
ES2135589T3 (es)	1999-11-01
CA2165335A1 (en)	1995-01-05
AU7112494A (en)	1995-01-17
AU678836B2 (en)	1997-06-12
GR3031218T3 (en)	1999-12-31
JPH08508891A (ja)	1996-09-24
EP0703978A1 (en)	1996-04-03
WO1995000632A1 (en)	1995-01-05

Publication	Publication Date	Title
GR3031218T3 (en)	1999-12-31	Medium for long-term proliferation and development of cells
Rodeck et al.	1987	Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors
JP2577114B2 (ja)	1997-01-29	細胞培養基
Vunjak‐Novakovic et al.	2002	Bioreactor studies of native and tissue engineered cartilage
CN101412985B (zh)	2012-06-13	用于骨髓间充质干细胞体外培养和扩增的无血清培养基
AU1380400A (en)	2000-05-29	Serum free medium for chondrocyte-like cells
DE69928678D1 (de)	2006-01-05	Verwendung von wachstumsfaktoren und hormonen zur vermehrung menschlicher chondrozyten und knorpelgewebeherstellung
CN110257328A (zh)	2019-09-20	一种间充质干细胞无血清培养基
Wu et al.	1978	Replacement of serum in cell culture by hormones: A study of hormonal regulation of cell growth and specific gene expression
IL138417A0 (en)	2001-10-31	Immortalised cell lines derived from normal human skin tissues
Rheinwald	1979	The role of terminal differentiation in the finite culture lifetime of the human epidermal keratinocyte
KR20110097064A (ko)	2011-08-31	무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법
EP2746386A1 (en)	2014-06-25	Materials and methods for cell culture
ATE191501T1 (de)	2000-04-15	Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen
EP0939797B1 (en)	2007-03-07	Defined systems for epithelial cell culture and use thereof
Slavkin et al.	1990	Cartilage, bone and tooth induction during early embryonic mouse mandibular morphogenesis using serumless, chemically-defined medium
Schrimpf et al.	1993	Growth of human vascular endothelial cells on various types of microcarriers
Martin et al.	1981	Extracellular matrix proteins give new life to cell culture
CN112342187A (zh)	2021-02-09	一种软骨细胞培养基及其制备方法
CN113667632B (zh)	2023-10-17	细胞培养基添加剂、细胞培养基及细胞体外扩增的方法
Ponting	1996	Medium for long-term proliferation and development of cells
Gauss et al.	1981	Change in the expression of collagen genes in dividing and nondividing chondrocytes
Villanueva et al.	1989	Cells isolated from fetal rat calvaria by isopycnic separation express different collagen phenotypes
Vlodavsky et al.	1982	Stimulation of human amniotic fluid cell proliferation and colony formation by cell plating on a naturally produced extracellular matrix
Green	1978	Cell culture for the study of epithelial cells